Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Salidroside-Based Nanomedicines for Triple-Negative Breast Cancer: From Molecular Mechanisms to Clinical Translation

Saved in:
Bibliographic Details
Published in:Breast Cancer : Targets and Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868938310613729281
collection WordPress RSS
FRELIP Feed Integration
container_title Breast Cancer : Targets and Therapy
description
discipline_display Oncology
discipline_facet Oncology
format Online Article
RSS Article
genre Journal Article
id rss_article:95423
institution FRELIP
journal_source_facet Breast Cancer : Targets and Therapy
last_indexed 2026-06-25T03:34:24.930Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Salidroside-Based Nanomedicines for Triple-Negative Breast Cancer: From Molecular Mechanisms to Clinical Translation
Oncology
General
Oncology
sub_discipline_display General
sub_discipline_facet General
subject_display Oncology
General
Oncology
subject_facet Oncology
General
Oncology
title Salidroside-Based Nanomedicines for Triple-Negative Breast Cancer: From Molecular Mechanisms to Clinical Translation
title_alt Nanomedicamentos basados en salidrósido para el cáncer de mama triple negativo: desde mecanismos moleculares hasta la traducción clínica
Nanomédicaments à base de salidroside pour le cancer du sein triple négatif : des mécanismes moléculaires à la traduction clinique
Nanomedicamentos à Base de Salidrosídeo para Câncer de Mama Triplo Negativo: Dos Mecanismos Moleculares à Tradução Clínica
title_auth Salidroside-Based Nanomedicines for Triple-Negative Breast Cancer: From Molecular Mechanisms to Clinical Translation
title_es_txt Nanomedicamentos basados en salidrósido para el cáncer de mama triple negativo: desde mecanismos moleculares hasta la traducción clínica
title_fr_txt Nanomédicaments à base de salidroside pour le cancer du sein triple négatif : des mécanismes moléculaires à la traduction clinique
title_full Salidroside-Based Nanomedicines for Triple-Negative Breast Cancer: From Molecular Mechanisms to Clinical Translation
title_fullStr Salidroside-Based Nanomedicines for Triple-Negative Breast Cancer: From Molecular Mechanisms to Clinical Translation
title_full_unstemmed Salidroside-Based Nanomedicines for Triple-Negative Breast Cancer: From Molecular Mechanisms to Clinical Translation
title_pt_txt Nanomedicamentos à Base de Salidrosídeo para Câncer de Mama Triplo Negativo: Dos Mecanismos Moleculares à Tradução Clínica
title_short Salidroside-Based Nanomedicines for Triple-Negative Breast Cancer: From Molecular Mechanisms to Clinical Translation
title_sort salidroside-based nanomedicines for triple-negative breast cancer: from molecular mechanisms to clinical translation
topic Oncology
General
Oncology
url https://www.dovepress.com/salidroside-based-nanomedicines-for-triple-negative-breast-cancer-from-peer-reviewed-fulltext-article-BCTT